Hyperliquid Labs has begun unstaking 3.75 million HYPE tokens, valued at approximately $329 million when the transaction was disclosed, ahead of an over-the-counter sale of the entire allocation to a single institutional buyer.
The tokens are associated with Hyperliquid’s October team distribution. Co-founder iliensinc disclosed through the project’s Discord that the batch is covered by an institutional OTC agreement and will not be sold through the open market.
The unstaking process began around September 30 and October 1, rather than October 7 itself. Hyperliquid’s staking system imposes a seven-day waiting period when HYPE is transferred from a staking balance back to a spot balance, putting completion of the process around October 7.
At roughly $329 million, the 3.75 million-token batch was worth approximately $87.70 per HYPE using the valuation reported when the deal emerged. Other estimates reached roughly $337 million as HYPE’s market price moved higher, illustrating that the headline figure represents the tokens’ market value rather than the disclosed purchase price of the OTC transaction.
OTC Deal Avoids Immediate Order-Book Sale
The structure matters because an OTC transaction differs substantially from selling 3.75 million HYPE directly into public markets.
Instead of submitting sell orders against available exchange liquidity, the seller and institutional counterparty negotiate privately and transfer the assets directly. That removes the immediate mechanical selling pressure that could accompany a market disposal of similar size.
The batch represents roughly 1.5% of HYPE’s circulating supply, making an equivalent open-market sale potentially significant.
However, the OTC structure does not permanently remove those tokens from liquid supply. The institutional buyer has not been publicly identified, and neither the actual transaction price nor any mandatory lock-up period has been disclosed. Consequently, the buyer could theoretically hold, stake or eventually transfer some or all of the HYPE to exchanges after receiving it.
That makes October 7 relevant primarily as the point at which the tokens become transferable after completing Hyperliquid‘s unstaking queue — not necessarily the date when $329 million of HYPE suddenly enters public markets.
Team Supply Moves to an Institutional Holder
The transaction also changes the composition of HYPE ownership. Hyperliquid’s genesis distribution allocated 23.8% of maximum HYPE supply to current and future core contributors, with those tokens subject to vesting restrictions. The October distribution forms part of the continuing release of team-related supply.
Normally, token unlocks attract attention because previously restricted assets become available to holders who may choose to sell.
This transaction changes that immediate dynamic because a single institutional counterparty has agreed to absorb the 3.75 million HYPE away from public order books.
It should therefore not be described as Hyperliquid dumping $329 million of HYPE onto the market.
At the same time, an OTC buyer does not eliminate longer-term supply risk. Once the seven-day withdrawal completes, public blockchain activity can provide evidence of whether the institution holds the tokens, restakes them or subsequently transfers them toward exchange addresses.
HYPE traded around $90 as news of the arrangement circulated, with the token initially rising rather than falling as traders assessed the reduced prospect of immediate open-market selling.
The most important unknown remains the institution itself and the terms of the transaction. Hyperliquid has not publicly disclosed the buyer, the negotiated price or whether the counterparty has agreed to any holding restrictions.
The confirmed development is narrower: Hyperliquid Labs is unstaking 3.75 million HYPE from its October team allocation, worth roughly $329 million when announced, with the batch earmarked for a single institutional buyer through an OTC transaction rather than an open-market sale.